All News #Library
Biotech
UK`s Epsilogen acquires fellow immunoglobin biotech TigaTx
08 Apr 2025 //
FIERCE BIOTECH
Epsilogen Acquires TigaTx, Inc. to Create Leading Cancer Antibody
07 Apr 2025 //
BUSINESSWIRE
Epsilogen Announces Initiation of Phase Ib Trial of MOv18 IgE
02 Dec 2024 //
BUSINESSWIRE
Epsilogen Completes £12.5 Million Series B Financing Expansion
09 Sep 2024 //
BUSINESSWIRE
Epsilogen`s MOv18 IgE CTA Approved For Phase Ib In Resistant Ovarian Cancer
08 Jul 2024 //
BUSINESSWIRE

Market Place
Sourcing Support